SCHEMBL11354660

SCHEMBL11354660

Cc1cc(C(=O)Nc2cc(S(=O)(=O)O)cc3cc(O)ccc23)ccc1NC(=O)Nc1ccc(C(=O)Nc2cc(S(=O)(=O)O)cc3cc(O)ccc23)cc1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.46
▸ KMT2A Q03164 4/20 0.46
▸ TDP1 Q9NUW8 4/20 0.46
▸ MAPT P10636 3/20 0.46
▸ LMNA P02545 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ PRMT1 Q99873 2/20 0.44
▸ HPSE Q9Y251 2/20 0.44
▸ TIMP3 P35625 5/20 0.43
▸ P2RY11 Q96G91 2/20 0.43
▸ USP2 O75604 2/20 0.43
▸ RECQL P46063 2/20 0.43
▸ HSD17B10 Q99714 2/20 0.43
▸ ENPP3 O14638 1/20 0.43
▸ ENTPD3 O75355 1/20 0.43
▸ NR1I2 O75469 1/20 0.43
▸ PRKD3 O94806 1/20 0.43
▸ TDP2 O95551 1/20 0.43
▸ CBX7 O95931 1/20 0.43
▸ NSD2 O96028 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10905168 0.94 MEN1 (0.46) MEN1KMT2ATDP1MAPTLMNA
SCHEMBL11339174 0.91 HPSE (0.46) MEN1KMT2ATDP1MAPTLMNA
SCHEMBL11354729 0.91 PRMT1 (0.44) MEN1KMT2ATDP1MAPTLMNA
SCHEMBL11433965 0.87 CASP6 (0.48) MEN1KMT2ATDP1MAPTLMNA
SCHEMBL11427527 0.85 CASP6 (0.48) MEN1KMT2ATDP1MAPTLMNA
SCHEMBL10909117 0.85 MEN1 (0.46) MEN1KMT2ATDP1MAPTLMNA
SCHEMBL10908373 0.85 CASP6 (0.43) MEN1KMT2ATDP1MAPTLMNA
SCHEMBL11352224 0.84 PRMT1 (0.57) MEN1KMT2ATDP1MAPTPRMT1
SCHEMBL11425435 0.83 POLB (0.50) MEN1KMT2ATDP1MAPTLMNA
SCHEMBL10823744 0.83 PRMT1 (0.44) MEN1KMT2ATDP1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4297372-A ANTIARTHRITIC AGENTS; COLLAGENASE AND PROTEOLYTIC ENZYME INHIBITORS; BONE, SKIN, AND ORAL DISORDERS AMERICAN CYANAMID COMPANY (US) 1981-10-27 — — US disclosed
EP-0013784-A1 C-Substituted naphthalenemonosulfonic ureides, process for their preparation and pharmaceutical compositions containing them AMERICAN CYANAMID COMPANY (US) 1980-08-06 — — EP disclosed
US-4216164-A Ureide inhibitors of connective tissue destruction AMERICAN CYANAMID COMPANY (US) 1980-08-05 — — US disclosed
Send feedback